Related Experiment Video
Updated: Apr 20, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
[Current methods in genetic analysis : an approach for genetics-based preventive medicine].
1Zentrum für Humangenetik und Laboratoriumsdiagnostik (MVZ), Lochhamerstr. 29, 82152, Martinsried, Deutschland, klein@medizinische-genetik.de.
Modern genetic technologies like DNA arrays and Next Generation Sequencing (NGS) accelerate research but face challenges in broad disease prevention screening due to complex gene-environment interactions. Ethical considerations for genetic screening are also discussed.
Area of Science:
- Molecular Genetics
- Genomic Research
- Biotechnology
Context:
- The post-genomic era has seen rapid advancements driven by genome research.
- DNA arrays (gene chips) and Next Generation Sequencing (NGS) are key technologies accelerating innovation.
- These powerful tools are increasingly applied in large-scale scientific projects.
Purpose:
- To outline the evolution of molecular genetics methods.
- To present array and NGS technologies as major innovation drivers.
- To discuss applications in research, rare disease diagnosis, and screening approaches, including ethical considerations.
Summary:
- Introduces DNA arrays and NGS as pivotal methods in modern genetic analysis.
- Highlights their application in large-scale research projects.
- Notes limitations in broad disease prevention screening due to gene-environment complexity, with exceptions in pharmacogenetics and oncology.
Impact:
- Facilitates understanding of genetic analysis method development.
- Provides insights into the application of advanced genetic technologies in scientific research and diagnostics.
- Raises awareness of the complexities and ethical issues surrounding genetic population screening.
More Related Videos
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Principles of Pharmacogenetics: Types of Genetic Variants
Pharmacogenetics and Pharmacogenomics: Overview
Behavioral Genetics and Its Designs
The primary methodologies used in behavior genetics include family studies, twin studies, and adoption studies, each providing unique...